CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christensen, J. G.
Right arrow Articles by Goldsworthy, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christensen, J. G.
Right arrow Articles by Goldsworthy, T. L.

Cell Growth & Differentiation, Vol 9, Issue 9 815-825, Copyright © 1998 by American Association of Cancer Research


ARTICLES

Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens

JG Christensen, AJ Gonzales, RC Cattley and TL Goldsworthy
Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709-2137, USA. christensen@CIIT.org

Regulation of apoptosis is an important component of multistage hepatocarcinogenesis. The objectives of the present study were to characterize apoptosis regulation in primary mouse hepatocytes and to determine whether nongenotoxic carcinogens alter apoptosis regulation. Bleomycin-induced apoptosis was accompanied by decreases in bcl-2 and bcl-xl and increases in p53, bak, and bax protein levels. Transforming growth factor (TGF)-beta-induced apoptosis was accompanied by decreased bcl-xL and increased bak. Bleomycin-induced apoptosis was partially dependent on p53, whereas TGF-beta-induced apoptosis was independent of p53. Phenobarbital inhibited both TGF-beta and bleomycin-induced apoptosis and the normal regulation of p53, bcl-2, and bax. Nafenopin inhibited apoptosis through a mechanism dependent on PPAR-alpha and inhibited the normal regulation of bcl-2 and bak. 2,3,7,8-Tetrachlorodibenzo-p-dioxin did not alter apoptosis or its regulation. Apoptosis was increased in hepatocytes from bcl-2-null mice, which indicated that the bcl-2 family contributes to hepatocyte apoptosis regulation. This study demonstrated that apoptosis regulation in mouse hepatocytes involves distinct pathways and that diverse nongenotoxic carcinogens differentially alter molecular pathways that represent targets for hepatocarcinogenesis.


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
K.-T. Park, K. A. Mitchell, G. Huang, and C. J. Elferink
The Aryl Hydrocarbon Receptor Predisposes Hepatocytes to Fas-Mediated Apoptosis
Mol. Pharmacol., March 1, 2005; 67(3): 612 - 622.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B.-C. Kim, M. Mamura, K. S. Choi, B. Calabretta, and S.-J. Kim
Transforming Growth Factor {beta}1 Induces Apoptosis through Cleavage of BAD in a Smad3-Dependent Mechanism in FaO Hepatoma Cells
Mol. Cell. Biol., March 1, 2002; 22(5): 1369 - 1378.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. HERRERA, ALBERTO. M. ALVAREZ, A. SANCHEZ, M. FERNANDEZ, C. RONCERO, M. BENITO, and I. FABREGAT
Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor {beta} in fetal hepatocytes
FASEB J, March 1, 2001; 15(3): 741 - 751.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1998 by the American Association of Cancer Research.